Building access to the Regenstrief Institute is restricted at least through September 13, 2020. More on our coronavirus precautions.
See our coronavirus precautions.

Regenstrief Institute faculty member Shaun Grannis, M.D., participated in a private workshop in Washington, D.C. on considerations and potential best practices for large-scale curation of real-world data that could support regulatory decision-making. The panel was convened under a cooperative agreement between the U.S. Food and Drug Administration and Duke University Robert J. Margolis, M.D., Center for Health Policy. 

In the coming years, opportunities will emerge to make better use of real-world data within the FDA’s regulatory framework. More consistent use of that data can improve the efficiency of traditional randomized control trials, and there may be opportunities to leverage that data and evidence in support of supplemental approval or labeling actions. FDA officials are asking for the input of stakeholders from across the country to advance policy development related to the regulatory acceptability of real-word evidence. This workshop gathered perspective and explored best practices for the data curation process.

Dr. Grannis, who is the director for the Regenstrief Center for Biomedical Informatics and an associate professor at the Indiana University School of Medicine, shared his expertise on data integration. He spoke about the best strategies to link data together and the best methods to measure matching accuracy. Dr. Grannis’ research is focused on improving discovery and decision support by developing, testing and implementing innovative approaches for data integration, patient matching, predictive modeling and other novel data science use cases.

From here, the FDA will evaluate the input from the workshop and decide how it will influence future policies and practice. The agency is working to meet real-world evidence milestones as established in the 21st Century Cures Act and the sixth Prescription Drug User Fee Act.

MEDIA CONTACT:

John Erickson
Regenstrief Institute
jorerick@regenstrief.org
(317) 274-9062

Related News

Jul 07, 2020 • News
New healthcare codes released, including terms used internationally to track coronavirus
System provides common language for seamless exchange of health data in 179 countries LOINC®, created and maintained by the Regenstrief Institute, is amplifying its global work to help track the coronavirus by releasing new standardized codes for healthcare systems’ laboratory tests, clinical observations and other data. Health systems often have their own format for recording…
Continue Reading >
Jul 06, 2020 • News
During COVID-19 disruption, Regenstrief and CTSI offer free continuing education classes
60 from Notre Dame, IU, Purdue, Duke, Ohio State, Oregon participate Amid the work disruptions from COVID-19, Regenstrief Institute and Indiana Clinical and Translational Sciences Institute (CTSI) are providing free opportunities for research professionals to continue their education. After a successful launch to Regenstrief and Indiana University employees, the institute made classes available to Indiana…
Continue Reading >